Biodesix, Inc.
NPI 1538559919 · Clinical Medical Laboratory · Louisville, CO
Enrolled with Medicare as Part B Supplier - Independent Clinical Laboratory · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Biodesix, Inc. is a Clinical Medical Laboratory organization in Louisville, CO (NPI 1538559919).
Provider details
- NPI number
- 1538559919
- Entity type
- Organization
- Primary specialty
- Clinical Medical LaboratoryLaboratories
- Organization subpart
- No
- Authorized official
- Robin Harper Cowie, Chief Financial Officer(720) 509-8841
Specialties & taxonomies
Laboratories
- Clinical Medical Laboratory291U00000X
Laboratories
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
11 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
2,480 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Testing of Lung Tumor Cells for Prediction of Survival81538 | 781 | $2,814 |
| Gene Analysis (epidermal Growth Factor Receptor), Common Variants81235 | 450 | $318 |
| Gene Analysis (v-Raf Murine Sarcoma Viral Oncogene Homolog B1)81210 | 448 | $172 |
| Gene Analysis (v-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene) Variants in Codons 12 and 1381275 | 448 | $189 |
| Genomic Sequence Analysis Panel of Dna Or Combined Dna and Rna of 51 Or More Genes Associated With Blood and Lymphatic System Disorders81455 | 353 | $2,861 |
Typical Medicare-allowed amounts for these services range $172–$2,861 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.
Practice location
Mailing address
Registry dates
- Enumerated
- 2015-01-23
- Last updated
- 2025-07-29
- Certified
- 2025-07-29
Frequently asked questions
- What is Biodesix, Inc.'s NPI number?
- Biodesix, Inc.'s National Provider Identifier (NPI) is 1538559919, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What type of organization is Biodesix, Inc.?
- Biodesix, Inc. is classified in the NPPES registry as Clinical Medical Laboratory (Laboratories).
- Where is Biodesix, Inc. located?
- Biodesix, Inc.'s practice location on file with NPPES is 919 W Dillon Rd, Louisville, CO 80027-4007.
- What is Biodesix, Inc.'s phone number?
- The practice phone number listed in the NPPES registry for Biodesix, Inc. is (303) 417-0500.
- Does Biodesix, Inc. accept Medicare?
- Biodesix, Inc. is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Who is the authorized official for Biodesix, Inc.?
- The authorized official listed on Biodesix, Inc.'s NPPES record is Robin Harper Cowie, Chief Financial Officer. The authorized official registers and maintains the organization's NPI and is not necessarily its owner.
- Is Biodesix, Inc.'s NPI active?
- Yes — Biodesix, Inc.'s NPI (1538559919) is active in the NPPES registry as of the last update on 2025-07-29.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.